uPAR: A Promising Target for CAR T Cell Therapy in Solid Tumors
A groundbreaking advancement in cancer immunotherapy has emerged from the laboratories of Memorial Sloan Kettering Cancer Center (MSK), where scientists have engineered a novel chimeric...
















